Once inside, the virion reprograms the genetic material of the immune cell to produce more HIV virions. In this way, HIV disables the disease-fighting 'bodyguards' in our blood and turns them into ...

Once inside, the virion reprograms the genetic material of the immune cell to produce more HIV virions. In this way, HIV disables the disease-fighting 'bodyguards' in our blood and turns them into ...

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The ...

Recent discoveries about the way that HIV infects cells are propelling the development of a broad spectrum of promising new antiviral drugs, according to an invited commentary on the topic in the ...

"All HIV treatment to date has been based on the free-floating virion model," says Benjamin K. Chen, MD, PhD, an Associate Professor of Infectious Diseases, Microbiology, and Immunology at the ...

By contrast, the HIV virion was known to have an asymmetrical form, and it has also been established that many viruses have some variance in the stable structures they can assume.

When HIV enters the cell, the bond formed between LIF and its receptor prompts the release of other, ... Virion, a biotechnology company in Michigan, holds a patent on HIV-related uses of LIF.

Substantial agreement exists that Nef forms a complex with Pak2 (Figure 1, Orange). [65,100,103,104] Nef not only complexes with Pak2 but also induces Pak2 activation [49,105] The ability of Nef ...

While HIV cell-to-cell transmission has been observed in test tube experiments, this is the first study to capture these interactions in a living animal. Although cell-to-cell infection does ...